ArticleCancer research communications2022

The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent Cancer Models.

Caroline Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.